Healiva SA

Healiva is a patient centric Biotech company, and we use a multi-pronged approach to address patient needs by combining enzyme technology, medical devices, and cell therapy to deliver precision solutions for chronic wounds. Our business value arises from our unique standing in offering comprehensive end-to-end solutions targeting the unmet needs of the chronic wound care spectrum. This differentiates us from competitors. Our portfolio enables a rapid timeline to market entry, driving our quick revenue generation business model. This allows us to take advantage of strategic commercialisation options with existing wound care players, establishing our presence in this growing multi-billion dollar global market.